(S (NP-SBJ (NP (NN Activation)) (PP (IN of) (NP (JJ nuclear) (NN factor-kappaB))) (PP (IN via) (NP (NN T) (NN cell) (NN receptor)))) (VP (VBZ requires) (NP (DT a) (NP-COOD (NP (NN Raf) (NN kinase)) (CC and) (NP (NN Ca2+))) (NN influx))) (. .))
(NP (NP (JJ Functional) (NN synergy)) (PP (IN between) (NP-COOD (NP (NN Raf)) (CC and) (NP (NN calcineurin)))) (. .))
(S (NP-SBJ (NP (NNS Signals)) (VP (VBN transduced) (NP (-NONE- *)) (PP (IN via) (NP (DT the) (NN TCR))))) (VP (VBP activate) (NP (NP (DT the) (NN transcription) (NN factor) (NP (NP (JJ nuclear) (NN factor-kappaB)) (PRN (-LRB- -LRB-) (NP (NN NF-kappaB)) (-RRB- -RRB-)))) (, ,) (SBAR (WHNP-41 (WDT which)) (, ,) (S (NP-SBJ (-NONE- *T*-41)) (PP (IN in) (NP (NN turn))) (, ,) (VP (VBZ is) (ADJP-PRD (JJ critical) (PP (TO to) (NP (NP (DT the) (JJ transcriptional) (NN induction)) (PP (IN of) (NP (NP (JJ many) (NNS genes)) (ADJP (JJ important) (PP (IN for) (NP (NP (DT the) (NP-COOD (NP (NN proliferation)) (CC and) (NP (NN expression)))) (PP (IN of) (NP (DT a) (VBN differentiated) (NN phenotype)))))))))))))))) (. .))
(S-COOD (S (NP-SBJ (NP (NN Treatment)) (PP (IN of) (NP (NN T) (NNS cells))) (PP (IN with) (NP (DT the) (NN protein) (NN kinase) (NN C) (NN activator) (NN PMA))) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (NN Ca2+) (NNS ionophores)))))) (VP (VBZ mimics) (NP (DT this) (NN process)))) (, ,) (CC and) (S (NP-SBJ-42 (DT the) (CD two) (NNS agents)) (VP (VBP are) (VP (ADVP-TMP (RB often)) (VBN substituted) (NP-43 (-NONE- *-42)) (PP (IN for) (NP (NN TCR) (NN stimulation)))) (, ,) (S (NP-SBJ (-NONE- *-43)) (VP (VBG bypassing) (NP (DT the) (NN TCR)))))) (. .))
(S (ADVP (RB Here)) (NP-SBJ (PRP we)) (VP (VBP identify) (NP (NP (JJ intracellular) (VBG signaling) (NNS components)) (VP (VBN involved) (NP (-NONE- *)) (PP (IN in) (NP (NP (NN activation)) (PP (IN of) (NP (NN NF-kappaB))) (PP-TMP (VBG following) (NP (NN TCR) (NN stimulation)))))))) (. .))
(S-COOD (S (NP-SBJ-44 (NN TCR) (NN signaling)) (VP (VBD was) (VP (VBN triggered) (NP (-NONE- *-44)) (PP (IN by) (S-LGS (NP-SBJ (-NONE- *)) (VP (VBG treating) (NP (NN Jurkat) (NN T) (NNS cells)) (PP (IN with) (NP (UCP (NP (NN PHA)) (CC or) (ADJP (JJ anti-CD3))) (NNS Abs))))))))) (, ,) (CC and) (S (NP-SBJ-45 (NN NF-kappaB) (NN activation)) (VP (VBD was) (VP (VBN monitored) (NP (-NONE- *-45)) (PP-COOD (PP (IN by) (NP (JJ electrophoretic) (NN mobility) (NN shift) (NNS assays))) (CC (or and)) (PP (IN by) (NP (JJ kappaB-dependent) (NN reporter) (NNS assays))))))) (. .))
(S (PP (JJ Contrary) (TO to) (NP (DT the) (NN idea) (SBAR (IN that) (S (NP-SBJ-46 (NN protein) (NN kinase) (NN C)) (VP (VBZ is) (VP (VBN involved) (NP (-NONE- *-46)) (PP (IN in) (NP (NP (JJ TCR-mediated) (NN activation)) (PP (IN of) (NP (NN NF-kappaB))))))))))) (, ,) (NP-SBJ (NP (JJ high) (NNS doses)) (PP (IN of) (NP (NN staurosporine)))) (VP (VBD did) (RB not) (VP (VB interfere) (PP (IN with) (NP (NP (NN activation)) (PP (IN of) (NP (NN NF-kappaB))) (PP (IN by) (NP (NN PHA))))) (, ,) (SBAR (IN while) (S (NP-SBJ (NP (DT the) (JJ same) (NN dose)) (PP (IN of) (NP (NN staurosporine)))) (ADVP (RB completely)) (VP (VBD blocked) (NP (NP (NN activation)) (PP (IN by) (NP (NN PMA))))))))) (. .))
(S (NP-SBJ-47 (JJ PHA-induced) (JJ kappaB-dependent) (NN reporter) (NN activity)) (VP (VBD was) (, ,) (ADVP (RB however)) (, ,) (VP (ADVP (RB effectively)) (VBN blocked) (NP (-NONE- *-47)) (PP (IN by) (NP-LGS (NP (DT a) (JJ dominant) (JJ negative) (NN form)) (PP (IN of) (NP (NN Raf-1))))) (, ,) (S (NP-SBJ (-NONE- *)) (VP (VBG suggesting) (NP (NP (DT a) (JJ critical) (NN role)) (PP (IN for) (NP (DT a) (NN Raf) (NN kinase)))))))) (. .))
(S (NP-SBJ (NP (DT The) (JJ TCR-mediated) (NN activation)) (PP (IN of) (NP (NN NF-kappaB)))) (VP (VBD was) (ADVP (RB also)) (ADJP-PRD (JJ dependent) (PP (IN on) (NP (DT a) (NN Ca2+) (NN influx)))) (, ,) (SBAR (IN because) (S (NP-SBJ-COOD (NP (NP (DT the) (NN Ca2+) (NN channel) (NN blocker)) (, ,) (NP (NN SK&amp;F) (CD 96365))) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (NP (JJ other) (NNS agents)) (SBAR (WHNP-49 (WDT that)) (S (NP-SBJ (-NONE- *T*-49)) (VP (VBD prevented) (NP (DT the) (NN Ca2+) (NN influx)))))) (, ,)) (VP (VBD inhibited) (NP (NN NF-kappaB) (NN activation)))))) (. .))
(S (NP-SBJ (NP (NN Cotransfection)) (PP (IN of) (NP (NP (DT a) (ADJP (RB constitutively) (JJ active)) (NN form)) (PP (IN of) (NP (NN calcineurin)))))) (VP-COOD (VP (ADVP (RB largely)) (VBD substituted) (PP (IN for) (NP (DT the) (NN Ca2+) (NN requirement)))) (CC and) (VP (VBD reversed) (NP (NP (DT the) (NN blockade)) (PP (IN by) (NP (NN SK&amp;F) (CD 96365)))))) (. .))
(S (ADJP (JJ Consistent) (PP (IN with) (NP (DT these) (NNS observations)))) (, ,) (NP-SBJ (NP (NN coexpression)) (PP (IN of) (NP (NP (ADJP (RB constitutively) (JJ active)) (NNS forms)) (PP (IN of) (NP-COOD (NP (NN Raf-1)) (CC and) (NP (NN calcineurin))))))) (ADVP (RB synergistically)) (VP (VBD induced) (NP (JJ kappaB-dependent) (NN reporter) (NN activity)) (, ,) (S (NP-SBJ (-NONE- *)) (VP (VBG suggesting) (NP (NP (DT a) (ADJP (RB physiologically) (JJ relevant)) (JJ functional) (NN interaction)) (PP (IN between) (NP-COOD (NP (DT the) (NN kinase)) (CC and) (NP (DT the) (NN phosphatase)))))))) (. .))
